Stocktoria
Arcus Biosciences, Inc. RCUS
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2018-03-15
Arcus Biosciences, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 9,763,113 | $148.7M |
| CITADEL ADVISORS LLC | 1,420,435 | $30.7M |
| RENAISSANCE TECHNOLOGIES LLC | 424,700 | $9.2M |
| TWO SIGMA INVESTMENTS, LP | 312,690 | $6.8M |
| D. E. Shaw & Co., Inc. | 259,400 | $5.6M |
| Point72 Asset Management, L.P. | 129,273 | $2.8M |
| AQR CAPITAL MANAGEMENT LLC | 86,294 | $1.9M |
Source: SEC EDGAR filings · CIK 0001724521 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.